Journal of Cerebral Blood Flow & Metabolism · 1988 · 248 citations · 20 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsAcute Ischemic StrokeGlutamatergic PharmacologyNeuroprotectionStrokeVeterinary NeuropharmacologyAnaesthetic Effects On Cerebral PhysiologyCerebral Ischemia NeuroprotectionCerebral Ischemia PharmacotherapyN-methyl-d-aspartate Receptor AntagonismN-methyl-d-aspartate Receptor InhibitionNeural IschemiaRodent Cerebral IschemiaStroke Neuroprotection
The effects of the glutamate N-methyl-D-aspartate receptor antagonist MK-801 in reducing ischaemic brain damage have been examined in anaesthetised cats, with drug treatment being initiated 2 h after the induction of cerebral ischaemia. Focal cerebral ischaemia was produced by permanent occlusion of one middle cerebral artery, and the animals were killed 6 h later. The amount of early irreversible ischaemic damage was assessed at 16 predetermined stereotactic planes. Treatment with MK-801 (5 mg/kg, i.v.) 2 h after middle cerebral artery occlusion reduced significantly the volume of ischaemic damage (from 1,625 +/- 384 mm3 of the cerebral hemisphere in vehicle-treated cats to 792 +/- 385 mm3 in MK-801-treated cats). The demonstration of reduced ischaemic brain damage with MK-801, when the agent is administered after the induction of ischaemia, extends the therapeutic potential of such agents in the treatment of focal cerebral ischaemia in humans.
20
Helene Benveniste, Jørgen Drejer, Arne Schousboe et al. · Journal of Neurochemistry · 1984 · 2.9K citations
Ionic dependence of glutamate neurotoxicity
DW Choi · Journal of Neuroscience · 1987 · 1.8K citations · Full text
Blockade of <i>N</i> -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
R. P. Simon, J. H. Swan, T. Griffiths et al. · Science · 1984 · 1.7K citations
Glutamate neurotoxicity in cortical cell culture
DW Choi, Margaret Maulucci-Gedde, AR Kriegstein · Journal of Neuroscience · 1987 · 1.4K citations · Full text